scispace - formally typeset
H

Hye Young Choi

Researcher at Kyung Hee University

Publications -  14
Citations -  605

Hye Young Choi is an academic researcher from Kyung Hee University. The author has contributed to research in topics: Pentacene & Spinal cord injury. The author has an hindex of 9, co-authored 14 publications receiving 529 citations.

Papers
More filters
Journal ArticleDOI

Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood–spinal cord barrier after spinal cord injury

TL;DR: Fluoxetine improved functional recovery in part by inhibiting matrix metalloprotease activation and preventing blood-spinal cord barrier disruption after spinal cord injury, and may represent a potential therapeutic agent for preserving blood-brain barrier integrity following ischaemic brain injury and spinal Cord injury in humans.
Journal ArticleDOI

Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury.

TL;DR: In this article, the authors examined whether valproic acid (VPA), a histone deacetylase inhibitor, would attenuate BSCB disruption by inhibiting matrix metalloprotease-9 activity, leading to improvement of functional outcome after SCI.
Journal ArticleDOI

Valproic acid protects motor neuron death by inhibiting oxidative stress and endoplasmic reticulum stress-mediated cytochrome C release after spinal cord injury.

TL;DR: In this article, the authors showed that valproic acid (VPA) reduced cell death of motor neurons by inhibiting cytochrome c release mediated by oxidative stress and endoplasmic reticulum (ER) stress.
Journal ArticleDOI

Fluoxetine inhibits transient global ischemia-induced hippocampal neuronal death and memory impairment by preventing blood-brain barrier disruption.

TL;DR: The study suggests that the neuroprotective effect of fluoxetine is likely mediated by blocking MMP activation followed BBB disruption after transient global ischemia, and the drug may represent a potential therapeutic agent for preserving BBB integrity following ischemic brain injury in humans.